These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 53713)

  • 1. Letter: Treatment of Wilson's disease.
    Bucur I; Hasselgren KH
    Lancet; 1975 Dec; 2(7946):1218. PubMed ID: 53713
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.
    Walshe JM
    Lancet; 1969 Dec; 2(7635):1401-2. PubMed ID: 4188283
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Drugs for rare diseases.
    Walshe JM
    Br Med J; 1975 Sep; 3(5985):701-2. PubMed ID: 1174857
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of chelation therapy on the amino aciduria and peptiduria of Wilson's disease.
    Asatoor AM; Milne MD; Walshe JM
    J R Coll Physicians Lond; 1983 Apr; 17(2):122-5. PubMed ID: 6842414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy in Wilson's disease.
    Reed K
    J Am Optom Assoc; 1988 Jun; 59(6):438. PubMed ID: 3403885
    [No Abstract]   [Full Text] [Related]  

  • 6. Trientine for Wilson's disease.
    Med Lett Drugs Ther; 1986 Jul; 28(717):67. PubMed ID: 3724656
    [No Abstract]   [Full Text] [Related]  

  • 7. Triethylene tetramine dihydrochloride in Wilson's disease.
    Dubois RS; Rodgerson DO; Slovis TL; Hambidge KM; Bianchi TA
    Lancet; 1970 Oct; 2(7676):775. PubMed ID: 4195996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Triethylene tetramine in Wilson's disease].
    Rave D; Vengrover D; Kleinman J; Leitersdorf E
    Harefuah; 1986 Feb; 110(4):178-9. PubMed ID: 3721331
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Wilson's disease using triethylenetetramine dihydrochloride (TETA)].
    Hauftová D; Körbel J; Jancík F; Kuhr I; Ferenc M
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):538-9. PubMed ID: 737791
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Wilson's disease].
    Pépin B; Barraine R
    Cah Coll Med Hop Paris; 1968 Feb; 9(2):184-7. PubMed ID: 5745277
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Wilson's disease.
    Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
    Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).
    Walshe JM
    Prog Clin Biol Res; 1979; 34():271-80. PubMed ID: 531055
    [No Abstract]   [Full Text] [Related]  

  • 14. New oral chelating agent for treatment of Wilson's disease.
    O'Reilly S; Bank W
    Nature; 1966 Dec; 212(5070):1597-8. PubMed ID: 21105526
    [No Abstract]   [Full Text] [Related]  

  • 15. Wilson's disease: clinical management and therapy.
    Brewer GJ; Askari FK
    J Hepatol; 2005; 42 Suppl(1):S13-21. PubMed ID: 15777568
    [No Abstract]   [Full Text] [Related]  

  • 16. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
    Ritland S
    Tidsskr Nor Laegeforen; 1987 Aug; 107(22):1770-1. PubMed ID: 3660361
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson's disease.
    Dixon HB; Gibbs K; Walshe JM
    Lancet; 1972 Apr; 1(7755):853. PubMed ID: 4111619
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of Wilson's disease recovering from severe brain damage--special reference to trientine and D-penicillamine therapy].
    Ishitsu T; Chikazawa S
    No To Hattatsu; 1989 May; 21(3):294-6. PubMed ID: 2736129
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
    Haslam RH; Sass-Kortsak A; Stout W; Berg M
    Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilson's disease in one identical twin and treatment by triethylene tetramine 2HCl in another case.
    Watson RG
    Ulster Med J; 1983; 52(1):48-53. PubMed ID: 6687321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.